Page last updated: 2024-10-16

adenine and Tumour Lysis Syndrome

adenine has been researched along with Tumour Lysis Syndrome in 6 studies

Research Excerpts

ExcerptRelevanceReference
"Discussion One patient with chronic lymphocytic leukemia/small lymphocytic lymphoma and one patient with mantle cell lymphoma developed laboratory and clinical tumor lysis syndrome following initiation of ibrutinib therapy."2.58Ibrutinib-associated tumor lysis syndrome in chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma: A case series and review of the literature. ( Brown, JN; Hammond, JM; Titus-Rains, KS, 2018)
"Tumor lysis syndrome is an oncologic emergency resulting from rapid and massive tumor cell death that may lead to serious clinical complications including acute kidney injury and cardiac arrest."1.56Bruton's tyrosine kinase inhibitors and the kidney: Focus on ibrutinib. ( Brener, H; Brener, ZZ; Losev, A, 2020)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Barr, PM2
Tedeschi, A1
Wierda, WG2
Allan, JN1
Ghia, P2
Vallisa, D1
Jacobs, R1
O'Brien, S2
Grigg, AP1
Walker, P1
Zhou, C2
Ninomoto, J2
Krigsfeld, G1
Tam, CS2
Brener, ZZ1
Brener, H1
Losev, A1
Titus-Rains, KS1
Brown, JN1
Hammond, JM1
Byrd, JC1
Coutre, S1
Furman, RR1
Kipps, TJ1
Burger, JA1
Stevens, DA1
Sharman, J1
Flinn, IW1
James, DF1
Kaur, V2
Mehta, P1
Johnsurd, J1
Govindarajan, R1
Swami, A1

Reviews

1 review available for adenine and Tumour Lysis Syndrome

ArticleYear
Ibrutinib-associated tumor lysis syndrome in chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma: A case series and review of the literature.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2018, Volume: 24, Issue:7

    Topics: Adenine; Aged; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Male; Piperidi

2018

Other Studies

5 other studies available for adenine and Tumour Lysis Syndrome

ArticleYear
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 10-14, Volume: 28, Issue:20

    Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cr

2022
Bruton's tyrosine kinase inhibitors and the kidney: Focus on ibrutinib.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:7

    Topics: Adenine; Aged; Humans; Kidney; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Piperidines; Protein Ki

2020
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
    British journal of haematology, 2019, Volume: 186, Issue:1

    Topics: Adenine; Aged; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male;

2019
Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia.
    Blood, 2014, Nov-27, Volume: 124, Issue:23

    Topics: Adenine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Pyrazoles;

2014
Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: A case report.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2017, Volume: 23, Issue:3

    Topics: Adenine; Aged; Antineoplastic Agents; Humans; Lymphoma, Mantle-Cell; Male; Piperidines; Protein Kina

2017